COVID-SARS2 NSP13 Citations (3)
Originally described in: Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.Newman JA, Douangamath A, Yadzani S, Yosaatmadja Y, Aimon A, Brandao-Neto J, Dunnett L, Gorrie-Stone T, Skyner R, Fearon D, Schapira M, von Delft F, Gileadi O Nat Commun. 2021 Aug 11;12(1):4848. doi: 10.1038/s41467-021-25166-6. PubMed Journal
Articles Citing COVID-SARS2 NSP13
| Articles |
|---|
Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase.
Newman JA, Douangamath A, Yadzani S, Yosaatmadja Y, Aimon A, Brandao-Neto J, Dunnett L, Gorrie-Stone T, Skyner R, Fearon D, Schapira M, von Delft F, Gileadi O.
Nat Commun. 2021 Aug 11;12(1):4848. doi: 10.1038/s41467-021-25166-6.
PubMed
Associated Plasmids |
| Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach. Romeo I, Ambrosio FA, Costa G, Corona A, Alkhatib M, Salpini R, Lemme S, Vergni D, Svicher V, Santoro MM, Tramontano E, Ceccherini-Silberstein F, Artese A, Alcaro S. Molecules. 2022 Nov 3;27(21):7522. doi: 10.3390/molecules27217522. PubMed |
| DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action. Iaconis D, Caccuri F, Manelfi C, Talarico C, Bugatti A, Filippini F, Zani A, Novelli R, Kuzikov M, Ellinger B, Gribbon P, Riecken K, Esposito F, Corona A, Tramontano E, Beccari AR, Caruso A, Allegretti M. Viruses. 2023 May 9;15(5):1128. doi: 10.3390/v15051128. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.